ConductScience.org, home

Paper6282974

CT hybridomas: tumor cells capable of lysing virally infected target cells.

Whitaker RB and 3 others. J Immunol, 1982. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. CT hybridomas: tumor cells capable of lysing virally infected target cells. Papers, record 6282974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6282974

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CT hybridomas: tumor cells capable of lysing virally infected target cells.
PubMed
Journal
J Immunol
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2007-11-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Whitaker RBR B
2Kauffman RSR S
3Che MM
4Finberg RR

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
HybridomasMajor topic
LymphomaMajor topic
T-LymphocytesMajor topic
Animals
Concanavalin A
Female
H-2 Antigens
Mice
Mice, Inbred C3H
Reoviridae Infections

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
16701PHS HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
6609404Recent developments in immunovirology.Surv Immunol Res1984https://conductscience.org/library/papers/6609404PubMed
6386143Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.Cancer Metastasis Rev1984https://conductscience.org/library/papers/6386143PubMed
6223945Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man.J Clin Invest1983https://conductscience.org/library/papers/6223945PubMed
1644447Inducible functions in hybrids of a Lyt-2+ BW5147 transfectant and the 2C CTL line.Immunogenetics1992https://conductscience.org/library/papers/1644447PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6282974

GET https://conductscience.org/api/papers/v1/6282974/authors